104 related articles for article (PubMed ID: 38788146)
1. Expression of somatostatin receptors in hemangioblastomas associated with von Hippel-Lindau disease as a novel diagnostic, therapeutic, and follow-up opportunity: A case report and literature review.
Brabo EP; de Almeida SA; Rafful PP; Rosado-de-Castro PH; Vieira Neto L
Arch Endocrinol Metab; 2024 May; 68():e230181. PubMed ID: 38788146
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target.
Sizdahkhani S; Feldman MJ; Piazza MG; Ksendzovsky A; Edwards NA; Ray-Chaudhury A; Maric D; Merrill MJ; Pacak K; Zhuang Z; Chittiboina P
Sci Rep; 2017 Jan; 7():40822. PubMed ID: 28094316
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG and 68Ga-DOTATATE PET/CT in von Hippel-Lindau Disease-Associated Retinal Hemangioblastoma.
Papadakis GZ; Millo C; Jassel IS; Bagci U; Sadowski SM; Karantanas AH; Patronas NJ
Clin Nucl Med; 2017 Mar; 42(3):189-190. PubMed ID: 28033220
[TBL] [Abstract][Full Text] [Related]
4. 68Ga DOTATATE PET/CT Versus 18F-FDG PET/CT for Detecting Intramedullary Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.
Banezhad F; Kiamanesh Z; Emami F; Sadeghi R
Clin Nucl Med; 2019 Jun; 44(6):e385-e387. PubMed ID: 30985433
[TBL] [Abstract][Full Text] [Related]
5. Suprasellar Hemangioblastoma on 68 Ga-DOTATATE PET/CT.
Filizoglu N; Ozguven S
Clin Nucl Med; 2022 Nov; 47(11):e700-e701. PubMed ID: 35695763
[TBL] [Abstract][Full Text] [Related]
6. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
7. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
[TBL] [Abstract][Full Text] [Related]
8. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
[TBL] [Abstract][Full Text] [Related]
9. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
[TBL] [Abstract][Full Text] [Related]
10. Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.
Hou G; Cheng X; Chi Y; Wang X; Zheng R
Clin Nucl Med; 2024 Mar; 49(3):289-291. PubMed ID: 38306383
[TBL] [Abstract][Full Text] [Related]
11. Incidence of von Hippel-Lindau disease in hemangioblastoma patients: the University of Tokyo Hospital experience from 1954-1998.
Sora S; Ueki K; Saito N; Kawahara N; Shitara N; Kirino T
Acta Neurochir (Wien); 2001 Sep; 143(9):893-6. PubMed ID: 11685621
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease.
Jagannathan J; Lonser RR; Smith R; DeVroom HL; Oldfield EH
J Neurosurg; 2008 Feb; 108(2):210-22. PubMed ID: 18240914
[TBL] [Abstract][Full Text] [Related]
14. Indium-111 pentetreotide uptake within cerebellar hemangioblastoma in von Hippel-lindau syndrome.
Chowdhury FU; Scarsbrook AF
Clin Nucl Med; 2008 Apr; 33(4):294-6. PubMed ID: 18356676
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study.
Kano H; Shuto T; Iwai Y; Sheehan J; Yamamoto M; McBride HL; Sato M; Serizawa T; Yomo S; Moriki A; Kohda Y; Young B; Suzuki S; Kenai H; Duma C; Kikuchi Y; Mathieu D; Akabane A; Nagano O; Kondziolka D; Lunsford LD
J Neurosurg; 2015 Jun; 122(6):1469-78. PubMed ID: 25816088
[TBL] [Abstract][Full Text] [Related]
16. Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas: benefits, risks and outcome.
Pavesi G; Feletti A; Berlucchi S; Opocher G; Martella M; Murgia A; Scienza R
J Neurosurg Sci; 2008 Jun; 52(2):29-36. PubMed ID: 18500215
[TBL] [Abstract][Full Text] [Related]
17. Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment.
Ammerman JM; Lonser RR; Dambrosia J; Butman JA; Oldfield EH
J Neurosurg; 2006 Aug; 105(2):248-55. PubMed ID: 17219830
[TBL] [Abstract][Full Text] [Related]
18. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
19. Hemangioblastoma and mosaic von Hippel Lindau disease: rare presentation and review of the literature.
Whitman A; Damodharan S; Bhatia A; Puccetti D; Iskandar B
Childs Nerv Syst; 2023 May; 39(5):1361-1363. PubMed ID: 36708374
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
